This independent medical education activity features an expert interview focusing on important data from the recent oncology literature in the field of renal cell carcinoma.

Cora Sternberg, MD, FACP, is interviewed regarding the published results of VEG105192, a randomized, double-blind, placebo-controlled trial evaluating treatment with pazopanib in patients with advanced and/or metastatic renal cell carcinoma who had progressed on one prior cytokine-based systemic therapy and how these results may affect clinical practice.